P1369: HDAC INHIBITION INVOLVES CD26 EXPRESSION ON MULTIPLE MYELOMA CELLS VIA THE C-MYC/SP1-MEDIATED PROMOTER ACTIVATION AND OVERCOMES THERAPEUTIC RESISTANCE BY HUMANIZED ANTIBODY

Detalles Bibliográficos
Autores principales: Nishida, Hiroko, Suzuki, Reiko, Nakajima, Kiyora, Morimoto, Chikao, Sakamoto, Michiie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430615/
http://dx.doi.org/10.1097/01.HS9.0000972364.58654.66
_version_ 1785091008347766784
author Nishida, Hiroko
Suzuki, Reiko
Nakajima, Kiyora
Morimoto, Chikao
Sakamoto, Michiie
author_facet Nishida, Hiroko
Suzuki, Reiko
Nakajima, Kiyora
Morimoto, Chikao
Sakamoto, Michiie
author_sort Nishida, Hiroko
collection PubMed
description
format Online
Article
Text
id pubmed-10430615
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104306152023-08-17 P1369: HDAC INHIBITION INVOLVES CD26 EXPRESSION ON MULTIPLE MYELOMA CELLS VIA THE C-MYC/SP1-MEDIATED PROMOTER ACTIVATION AND OVERCOMES THERAPEUTIC RESISTANCE BY HUMANIZED ANTIBODY Nishida, Hiroko Suzuki, Reiko Nakajima, Kiyora Morimoto, Chikao Sakamoto, Michiie Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430615/ http://dx.doi.org/10.1097/01.HS9.0000972364.58654.66 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Nishida, Hiroko
Suzuki, Reiko
Nakajima, Kiyora
Morimoto, Chikao
Sakamoto, Michiie
P1369: HDAC INHIBITION INVOLVES CD26 EXPRESSION ON MULTIPLE MYELOMA CELLS VIA THE C-MYC/SP1-MEDIATED PROMOTER ACTIVATION AND OVERCOMES THERAPEUTIC RESISTANCE BY HUMANIZED ANTIBODY
title P1369: HDAC INHIBITION INVOLVES CD26 EXPRESSION ON MULTIPLE MYELOMA CELLS VIA THE C-MYC/SP1-MEDIATED PROMOTER ACTIVATION AND OVERCOMES THERAPEUTIC RESISTANCE BY HUMANIZED ANTIBODY
title_full P1369: HDAC INHIBITION INVOLVES CD26 EXPRESSION ON MULTIPLE MYELOMA CELLS VIA THE C-MYC/SP1-MEDIATED PROMOTER ACTIVATION AND OVERCOMES THERAPEUTIC RESISTANCE BY HUMANIZED ANTIBODY
title_fullStr P1369: HDAC INHIBITION INVOLVES CD26 EXPRESSION ON MULTIPLE MYELOMA CELLS VIA THE C-MYC/SP1-MEDIATED PROMOTER ACTIVATION AND OVERCOMES THERAPEUTIC RESISTANCE BY HUMANIZED ANTIBODY
title_full_unstemmed P1369: HDAC INHIBITION INVOLVES CD26 EXPRESSION ON MULTIPLE MYELOMA CELLS VIA THE C-MYC/SP1-MEDIATED PROMOTER ACTIVATION AND OVERCOMES THERAPEUTIC RESISTANCE BY HUMANIZED ANTIBODY
title_short P1369: HDAC INHIBITION INVOLVES CD26 EXPRESSION ON MULTIPLE MYELOMA CELLS VIA THE C-MYC/SP1-MEDIATED PROMOTER ACTIVATION AND OVERCOMES THERAPEUTIC RESISTANCE BY HUMANIZED ANTIBODY
title_sort p1369: hdac inhibition involves cd26 expression on multiple myeloma cells via the c-myc/sp1-mediated promoter activation and overcomes therapeutic resistance by humanized antibody
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430615/
http://dx.doi.org/10.1097/01.HS9.0000972364.58654.66
work_keys_str_mv AT nishidahiroko p1369hdacinhibitioninvolvescd26expressiononmultiplemyelomacellsviathecmycsp1mediatedpromoteractivationandovercomestherapeuticresistancebyhumanizedantibody
AT suzukireiko p1369hdacinhibitioninvolvescd26expressiononmultiplemyelomacellsviathecmycsp1mediatedpromoteractivationandovercomestherapeuticresistancebyhumanizedantibody
AT nakajimakiyora p1369hdacinhibitioninvolvescd26expressiononmultiplemyelomacellsviathecmycsp1mediatedpromoteractivationandovercomestherapeuticresistancebyhumanizedantibody
AT morimotochikao p1369hdacinhibitioninvolvescd26expressiononmultiplemyelomacellsviathecmycsp1mediatedpromoteractivationandovercomestherapeuticresistancebyhumanizedantibody
AT sakamotomichiie p1369hdacinhibitioninvolvescd26expressiononmultiplemyelomacellsviathecmycsp1mediatedpromoteractivationandovercomestherapeuticresistancebyhumanizedantibody

Ejemplares similares